Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;33(6):e13878.
doi: 10.1111/dth.13878. Epub 2020 Jul 6.

SARS-CoV-2 as possible inducer of viral reactivations

Affiliations
Comment

SARS-CoV-2 as possible inducer of viral reactivations

Giulia Ciccarese et al. Dermatol Ther. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Comment on

References

    1. Dursun R, Temiz SA. The clinics of HHV‐6 infection in COVID‐19 pandemic: Pityriasis rosea and Kawasaki disease. Dermatol Ther. 2020;e13730. 10.1111/dth.13730. - DOI - PMC - PubMed
    1. Broccolo F, Drago F, Careddu AM, et al. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus‐6 and ‐7. J Invest Dermatol. 2005;124:1234‐1240. - PubMed
    1. Drago F, Ranieri E, Malaguti F, Battifoglio ML, Losi E, Rebora A. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology. 1997;195:374‐378. - PubMed
    1. Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus‐7 and human herpesvirus‐6. J Invest Dermatol. 2002;119:793‐797. - PubMed
    1. Drago F, Ciccarese G, Rebora A, Broccolo F, Parodi A. Pityriasis rosea: a comprehensive classification. Dermatology. 2016;232:431‐437. 10.1159/000445375. - DOI - PubMed